Generali Investments CEE investicni spolecnost a.s. Has $6.75 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Generali Investments CEE investicni spolecnost a.s. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.5% in the 1st quarter, HoldingsChannel reports. The fund owned 12,879 shares of the healthcare conglomerate’s stock after purchasing an additional 1,219 shares during the period. Generali Investments CEE investicni spolecnost a.s.’s holdings in UnitedHealth Group were worth $6,745,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $32,000. Finally, Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $40,000. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on the company. Raymond James Financial lowered UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Royal Bank Of Canada cut their price target on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Mizuho cut their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Finally, UBS Group dropped their price objective on UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating on the stock in a report on Wednesday, June 25th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $415.57.

UnitedHealth Group Stock Up 0.4%

Shares of UnitedHealth Group stock opened at $308.69 on Friday. The company’s 50 day moving average price is $324.99 and its 200-day moving average price is $447.68. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $280.03 billion, a price-to-earnings ratio of 12.93, a P/E/G ratio of 1.48 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter in the prior year, the company posted $6.91 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Insiders Place Their Bets

In other news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director directly owned 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 in the last 90 days. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.